Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 18 studies | 33% ± 18% | |
oligodendrocyte | 16 studies | 54% ± 17% | |
oligodendrocyte precursor cell | 10 studies | 32% ± 13% | |
glutamatergic neuron | 8 studies | 43% ± 23% | |
capillary endothelial cell | 8 studies | 24% ± 7% | |
fibroblast | 7 studies | 23% ± 7% | |
GABAergic neuron | 7 studies | 37% ± 16% | |
interneuron | 6 studies | 30% ± 13% | |
retinal rod cell | 6 studies | 34% ± 16% | |
neuron | 5 studies | 32% ± 17% | |
astrocyte | 5 studies | 26% ± 7% | |
pericyte | 4 studies | 21% ± 6% | |
smooth muscle cell | 4 studies | 20% ± 3% | |
glomerular endothelial cell | 3 studies | 21% ± 1% | |
glial cell | 3 studies | 31% ± 3% | |
granule cell | 3 studies | 30% ± 12% | |
platelet | 3 studies | 25% ± 4% | |
connective tissue cell | 3 studies | 26% ± 8% | |
myofibroblast cell | 3 studies | 19% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 4132.00 | 2619 / 2642 | 99% | 30.63 | 695 / 705 |
prostate | 100% | 4927.74 | 244 / 245 | 85% | 9.89 | 425 / 502 |
breast | 99% | 3231.41 | 455 / 459 | 78% | 7.42 | 873 / 1118 |
adrenal gland | 100% | 2786.63 | 258 / 258 | 77% | 12.90 | 176 / 230 |
lung | 100% | 4606.26 | 576 / 578 | 67% | 5.86 | 769 / 1155 |
thymus | 99% | 2724.84 | 645 / 653 | 67% | 6.83 | 407 / 605 |
skin | 93% | 2814.41 | 1680 / 1809 | 68% | 13.34 | 323 / 472 |
kidney | 83% | 1444.80 | 74 / 89 | 67% | 10.49 | 608 / 901 |
intestine | 94% | 5809.39 | 912 / 966 | 47% | 3.59 | 248 / 527 |
ovary | 100% | 7207.39 | 180 / 180 | 40% | 2.70 | 171 / 430 |
esophagus | 83% | 5038.28 | 1203 / 1445 | 56% | 4.40 | 102 / 183 |
bladder | 100% | 6568.76 | 21 / 21 | 35% | 2.96 | 175 / 504 |
stomach | 75% | 2974.94 | 270 / 359 | 58% | 6.64 | 166 / 286 |
uterus | 99% | 6567.75 | 169 / 170 | 27% | 4.95 | 124 / 459 |
blood vessel | 100% | 10634.09 | 1335 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 3351.70 | 1198 / 1204 | 0% | 0 | 0 / 0 |
spleen | 98% | 2089.05 | 237 / 241 | 0% | 0 | 0 / 0 |
heart | 98% | 2872.44 | 842 / 861 | 0% | 0 | 0 / 0 |
pancreas | 6% | 76.06 | 19 / 328 | 85% | 9.77 | 152 / 178 |
eye | 0% | 0 | 0 / 0 | 69% | 6.50 | 55 / 80 |
tonsil | 0% | 0 | 0 / 0 | 29% | 1.34 | 13 / 45 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.76 | 5 / 29 |
muscle | 16% | 239.44 | 128 / 803 | 0% | 0 | 0 / 0 |
liver | 2% | 27.23 | 5 / 226 | 13% | 0.76 | 54 / 406 |
peripheral blood | 2% | 25.14 | 15 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001780 | Biological process | neutrophil homeostasis |
GO_0030010 | Biological process | establishment of cell polarity |
GO_0001525 | Biological process | angiogenesis |
GO_0097530 | Biological process | granulocyte migration |
GO_0034333 | Biological process | adherens junction assembly |
GO_0042552 | Biological process | myelination |
GO_0090138 | Biological process | regulation of actin cytoskeleton organization by cell-cell adhesion |
GO_1905710 | Biological process | positive regulation of membrane permeability |
GO_0007160 | Biological process | cell-matrix adhesion |
GO_0002523 | Biological process | leukocyte migration involved in inflammatory response |
GO_1902414 | Biological process | protein localization to cell junction |
GO_0034113 | Biological process | heterotypic cell-cell adhesion |
GO_0045176 | Biological process | apical protein localization |
GO_0033629 | Biological process | negative regulation of cell adhesion mediated by integrin |
GO_0034394 | Biological process | protein localization to cell surface |
GO_0090022 | Biological process | regulation of neutrophil chemotaxis |
GO_2000439 | Biological process | positive regulation of monocyte extravasation |
GO_0002250 | Biological process | adaptive immune response |
GO_0097241 | Biological process | hematopoietic stem cell migration to bone marrow |
GO_0033624 | Biological process | negative regulation of integrin activation |
GO_0035633 | Biological process | maintenance of blood-brain barrier |
GO_0019226 | Biological process | transmission of nerve impulse |
GO_0002318 | Biological process | myeloid progenitor cell differentiation |
GO_0098609 | Biological process | cell-cell adhesion |
GO_0016477 | Biological process | cell migration |
GO_0007286 | Biological process | spermatid development |
GO_0005902 | Cellular component | microvillus |
GO_0005615 | Cellular component | extracellular space |
GO_0070160 | Cellular component | tight junction |
GO_0031941 | Cellular component | filamentous actin |
GO_0005886 | Cellular component | plasma membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0044291 | Cellular component | cell-cell contact zone |
GO_0005911 | Cellular component | cell-cell junction |
GO_0043220 | Cellular component | Schmidt-Lanterman incisure |
GO_0033010 | Cellular component | paranodal junction |
GO_0098636 | Cellular component | protein complex involved in cell adhesion |
GO_0005923 | Cellular component | bicellular tight junction |
GO_0030057 | Cellular component | desmosome |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0098632 | Molecular function | cell-cell adhesion mediator activity |
GO_0005178 | Molecular function | integrin binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | JAM3 |
Protein name | Junctional adhesion molecule C (JAM-C) (JAM-2) (Junctional adhesion molecule 3) (JAM-3) [Cleaved into: Soluble form of JAM-C (sJAM-C)] Junctional adhesion molecule 3 |
Synonyms | UNQ859/PRO1868 |
Description | FUNCTION: Junctional adhesion protein that mediates heterotypic cell-cell interactions with its cognate receptor JAM2 to regulate different cellular processes . Plays a role in homing and mobilization of hematopoietic stem and progenitor cells within the bone marrow. At the surface of bone marrow stromal cells, it contributes to the retention of the hematopoietic stem and progenitor cells expressing JAM3 . Plays a central role in leukocytes extravasation by facilitating transmigration through the endothelium (By similarity). Plays a role in spermatogenesis where JAM2 and JAM3, which are respectively expressed by Sertoli and germ cells, mediate an interaction between both cell types and play an essential role in the anchorage of germ cells onto Sertoli cells and the assembly of cell polarity complexes during spermatid differentiation (By similarity). Also functions as a counter-receptor for ITGAM, mediating leukocyte-platelet interactions and is involved in the regulation of transepithelial migration of polymorphonuclear neutrophils (PMN) . Plays a role in angiogenesis . Plays a role in the regulation of cell migration (Probable). During myogenesis, it is involved in myocyte fusion (By similarity). .; FUNCTION: [Soluble form of JAM-C]: Promotes chemotaxis of vascular endothelial cells and stimulates angiogenesis. . |
Accessions | ENST00000441717.3 [Q9BX67-2] Q9BX67 ENST00000534549.5 ENST00000532252.5 H0YCW9 ENST00000299106.9 [Q9BX67-1] H0YD98 |